Madrigal Pharmaceuticals annual gross margin
2024
2025
Madrigal Pharmaceuticals Gross Margin Growth & History (MDGL)
Madrigal Pharmaceuticals's gross margin was 94.14% for fiscal 2025.
View full Madrigal Pharmaceuticals company overviewMadrigal Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 94.14% | −2.40 pp |
| 2024 | 2024-12-31 | 96.54% | — |
Madrigal Pharmaceuticals quarterly gross margin
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 89.02% | −6.72 pp |
| Q1 2026 | 2026-03-31 | 91.38% | −5.33 pp |
| Q4 2025 | 2025-12-31 | 92.39% | — |
| Q3 2025 | 2025-09-30 | 93.69% | — |
| Q2 2025 | 2025-06-30 | 95.74% | — |
| Q1 2025 | 2025-03-31 | 96.71% | — |
Madrigal Pharmaceuticals gross margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Madrigal Pharmaceuticals's gross margin decreased from 96.54% to 94.14%, a change of −2.40 percentage points. The latest reported quarter, Q2 2026, shows 89.02%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Madrigal Pharmaceuticals source filings ↗